IrB L1 To L3
IrB L1 To L3 by Thera-Zyme is a Vitamins & Minerals supplement, categorized as 'Other Combinations', featuring 7 ingredients. This product contains a blend of botanicals such as Raspberry (100mg), Marshmallow (100mg), Mullein (100mg), Stinging Nettle (100mg), and Psyllium (50mg), along with a Proprietary Plant Enzyme Blend (98mg). These ingredients are traditionally used for various purposes, including digestive and respiratory support. However, none of the individual ingredients are present at dosages considered clinically optimal based on current scientific evidence. The product received an N+ Score of 52, earning an F grade, placing it in the below-average tier. This score reflects potential concerns regarding the overall efficacy and potency of the botanical blend. It may appeal to those interested in a broad botanical formulation, but its low N+ Score suggests limited evidence-based support for its claims.
About This Product
IrB L1 To L3 by Thera-Zyme is a vitamins & minerals supplement containing 7 active ingredients. It has earned an N+ Score of 52/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Marshmallow | 100.000 mg | N/A |
| Raspberry | 100.000 mg | N/A |
| Psyllium | 50.000 mg | N/A |
| Plantain | 50.000 mg | N/A |
| Mullein | 100.000 mg | N/A |
| Stinging Nettle | 100.000 mg | N/A |
| Proprietary Plant Enzyme Blend | 98.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
